Navigation Links
VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
Date:4/4/2008

SAN FRANCISCO, April 4, 2008 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that the independent Data Safety Monitoring Board (DSMB) for its VIA-2291 Phase 2 clinical trial program recently met to review patient safety for its current Phase 2 studies. The DSMB observed a continued acceptable safety profile of VIA-2291 and recommended VIA continue its ongoing trials as planned.

"We are encouraged by the continued positive safety profile of VIA-2291 as we enroll more patients in our Phase 2 clinical program," said Adeoye Olukotun, M.D., chief medical officer for VIA Pharmaceuticals. "We believe that a drug that reduces inflammation, an underlying cause of atherosclerosis and complications including heart attack and stroke, would help to address a significant unmet medical need."

VIA recently announced enrollment completion of its Phase 2 carotid endarterectomy (CEA) trial and expects to present top-line results in the third quarter of 2008. Enrollment is also nearing completion for the company's acute coronary syndrome (ACS) Phase 2 trial and data is expected to follow soon after the CEA data. Patient enrollment continues in the FDG-PET study, the company's third Phase 2 clinical trial.

"With the recent completion of our CEA trial enrollment, and this positive DSMB recommendation, we continue to make significant progress with our Phase 2 clinical program, and remain on track to deliver our first proof of concept data later this year," said Lawrence K. Cohen, Ph.D., chief executive officer of VIA Pharmaceuticals.

About VIA-2291

VIA-2291 is a selective and reversible inh
'/>"/>

SOURCE VIA Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
3. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
6. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
7. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
8. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
9. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , September 4, 2015 Oramed ... a clinical-stage pharmaceutical company focused on the development of ... will participate in the upcoming Rodman & Renshaw 17 ... 8-10, 2015 in New York City ... will present a corporate overview on September 9, 2015. ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
(Date:9/4/2015)... , Sep. 04, 2015 ... ) has announced the addition of the ... Market, 2010-2019" report to their offering. ... polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. ... and cartilage matrix, sodium hyaluronate can lubricate ...
Breaking Medicine Technology:Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... -- ADVANCE FOR RELEASE AT 5 P.M. EST MONDAY, ... Patients,who undergo complete prostate removal are less likely to ... done by an,experienced surgeon in a hospital that does ... the Agency for Healthcare Research and,Quality, part of the ...
... Regions of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, ... placebo-controlled trials showed patients with moderate,to severe plaque psoriasis receiving ... each of the four body regions,(head, trunk, lower and upper ...
Cached Medicine Technology:Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 2Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 3Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today that ... of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , ... the consumer goods industry, it can be difficult for companies to navigate, stay ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Keeping mold ... and around the home is quite common. Mold can grow anywhere - on carpet, ... leaking pipes. Checking for excessive moisture and water in the home is key to ...
(Date:9/4/2015)... TX (PRWEB) , ... September 04, 2015 , ... Mike ... Iraq in 2007, will compete in the Ironman World Championships in Kona on October ... who have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... The ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are ... take great pride in the quality of our ophthalmology residency program. Our faculty places ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... Prop. D and E Seen as Destructive to Existing ... Medical Society,s board of directors has voted unanimously to ... will appear on the Special Election ballot of May ... programs, previously established by state voters, which are successfully ...
... May 5 Colgate and the Hispanic Dental,Association officially ... Mundo de,Sonrisas Saludables (Oral Health Month: A World of ... oral care among the Hispanic community.,The Latino population has ... other ethnicity and ranks the highest for untreated dental ...
... Derma Sciences (OTC Bulletin Board: ... today announced that it intended to voluntarily delist its common ... and that it would file Form 25 with the Securities ... effect this delisting.Ed Quilty, CEO of Derma Sciences, noted that, ...
... PreXion adds automated high-resolution panoramic imaging capability to ... PreXion 3D Viewer.SAN MATEO, Calif., May 5 ... in dental and industrial CT systems, today announced ... 3D CBCT scanner and the PreXion 3D Viewer, ...
... with elevated albumin levels were more likely to get ... News) -- A higher-than-normal level of the protein albumin ... clots in the deep veins of the lungs and ... (VTEs) include deep vein thrombosis (DVT), a clotting in ...
... disease, but there,s a promising new procedure being performed at Abington ... ... Abington, PA (PRWEB) May 5, 2009 -- There,s new ... Memorial Hospital where doctors are performing a procedure to bypass, ...
Cached Medicine News:Health News:Colgate Bright Smiles, Bright Futures(R) Kids' Initiative Visits Union City, NJ 2Health News:Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange 2Health News:PreXion Adds High-resolution Panoramic Imaging 2Health News:Urine Test Predicts Vein Clot Risk 2Health News:Urine Test Predicts Vein Clot Risk 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 2Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 4
... computer-generated Thermal Printing Wristbands and Tags ... thermal and thermal transfer printers. Direct ... a heat-sensitive thermal coating under the ... use heat to transfer highly durable ...
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability....
... more secure band is desired for adults and where ... is appropriate. The design allows for two bands to ... placed on the wrist and the second to be ... replaced. This is particularly useful in a hospital situation ...
... ID system which combines the IDENTI-MATCH Blood Recipient ... six alert or warning ID bands. It is ... by hospital patients. It integrates the benefits of ... a multipurpose ID band that consolidates admitting and ...
Medicine Products: